Policy | August 03, 2021
API exports surpass imports by value in 2020-21
The govt has rolled out three schemes for promoting the manufacture of API
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
Essential medicines were made available to more than 150 countries around the world during the pandemic
Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The Profit After Tax (PAT) for Q3 FY26 was Rs 49.68 crore, compared to Rs 46.78 crore in Q3 FY25
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Subscribe To Our Newsletter & Stay Updated
